Lee Kalowski Homology Medicines, Inc. (FIXX) insider trading activity
Lee Kalowski is CFO and President of Homology Medicines, Inc.. Currently has a direct ownership of 53,250 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2025, when has been sold 53,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
53.3K
n/a
3M change
n/a
12M change
Total Value Held
$0
Lee Kalowski Transaction History
Also insider at
LK
Lee Kalowski
CFO and President
Cambridge, X0